328 related articles for article (PubMed ID: 29174320)
1. [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Yakoub-Agha I; Ferrand C; Chalandon Y; Ballot C; Castilla Llorente C; Deschamps M; Gauthier J; Labalette M; Larghero J; Maheux C; Moreau AS; Varlet P; Pétillon MO; Pinturaud M; Rubio MT; Chabannon C
Bull Cancer; 2017 Dec; 104(12S):S43-S58. PubMed ID: 29174320
[TBL] [Abstract][Full Text] [Related]
2. Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Yakoub-Agha I
Curr Res Transl Med; 2018 May; 66(2):57-58. PubMed ID: 29685843
[TBL] [Abstract][Full Text] [Related]
3. [Quality assessment of CAR T-cell activity: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Duléry R; Lacassagne MN; Giraud C; Ader V; Beaumont JL; Carnoy S; Carpentier A; Fegueux N; Gibault-Joffe C; Guerout-Verite MA; Huynh TNP; Lewalle P; Perrin A; Plaza-Milhe S; Bonnin A; Yakoub-Agha I; Contentin N
Bull Cancer; 2020 Dec; 107(12S):S193-S201. PubMed ID: 33187683
[TBL] [Abstract][Full Text] [Related]
4. CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success.
Long KB; Young RM; Boesteanu AC; Davis MM; Melenhorst JJ; Lacey SF; DeGaramo DA; Levine BL; Fraietta JA
Front Immunol; 2018; 9():2740. PubMed ID: 30559740
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.
Liu J; Zhong JF; Zhang X; Zhang C
J Hematol Oncol; 2017 Jan; 10(1):35. PubMed ID: 28143567
[TBL] [Abstract][Full Text] [Related]
6. Chimeric antigen receptor T-cell therapy to target hematologic malignancies.
Kenderian SS; Ruella M; Gill S; Kalos M
Cancer Res; 2014 Nov; 74(22):6383-9. PubMed ID: 25371415
[TBL] [Abstract][Full Text] [Related]
7. [Chimerism analysis after hematopoietic cell transplantation: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Dubois V; Alizadeh M; Bourhis JH; Etancelin P; Farchi O; Ferrand C; Goursaud L; Mollet I; Renac V; Varlet P; Yakoub-Agha I; Bay JO
Bull Cancer; 2017 Dec; 104(12S):S59-S64. PubMed ID: 29128084
[TBL] [Abstract][Full Text] [Related]
8. [CAR-T cells: Lymphocytes that express a chimeric antigen receptor].
Chabannon C; Bouabdallah R; Fürst S; Granata A; Saillard C; Vey N; Mokart D; Fougereau E; Lemarie C; Mfarrej B; Blaise D; Calmels B
Rev Med Interne; 2019 Aug; 40(8):545-552. PubMed ID: 30686549
[TBL] [Abstract][Full Text] [Related]
9. Adoptive therapy with CAR redirected T cells for hematological malignancies.
Li S; Yang Z; Shen J; Shan J; Qian C
Sci China Life Sci; 2016 Apr; 59(4):370-8. PubMed ID: 27009302
[TBL] [Abstract][Full Text] [Related]
10. [Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Rubio MT; Varlet P; Allain V; Ballot C; Cuffel A; Deschamps M; Ferrand C; Foguenne J; Forcade E; Huynh A; Guihot A; Latouche JB; Lemarie C; Martinroche G; Morin F; Nguyen S; Schmit K; Servais S; Simonetta F; Yakoub-Agha I; Caillat Zucman S
Bull Cancer; 2021 Dec; 108(12S):S53-S64. PubMed ID: 34253335
[TBL] [Abstract][Full Text] [Related]
11. [Gene-modified T-cell therapy using chimeric antigen receptors for pediatric hematologic malignancies].
Nakazawa Y
Rinsho Ketsueki; 2016 Jun; 57(6):701-8. PubMed ID: 27384848
[TBL] [Abstract][Full Text] [Related]
12. [Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Vasseur A; Karam M; Chaillou D; Colonnese E; Dantin C; Latiere C; Meziane Y; Pereira M; Yakoub-Agha I; Chabannon C; Raus N
Bull Cancer; 2020 Dec; 107(12S):S178-S184. PubMed ID: 31831153
[TBL] [Abstract][Full Text] [Related]
13. [Requirements for academic production of CAR-T cells in accordance with Good Pharmaceutical Practice (GMP). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Deschamps M; Decot V; Giverne C; Pinturaud M; Vaissié A; Parquet N; Olivero S; Anne-Claire M; Bay JO; Yakoub-Agha I; Ferrand C
Bull Cancer; 2020 Jan; 107(1S):S85-S93. PubMed ID: 31547937
[TBL] [Abstract][Full Text] [Related]
14. [Preservation/congelation of hematopoietic stem cell grafts in a pediatric context: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
De Vos J; de Berranger E; Jubert C; Pochon C; Letellier C; Mialou V; Sirvent A; Yakoub-Agha I; Dalle JH
Bull Cancer; 2017 Dec; 104(12S):S136-S141. PubMed ID: 29169651
[TBL] [Abstract][Full Text] [Related]
15. [The care process of patient receiving CAR T-cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Beauvais D; Andrianne C; Aubrun C; Berquier M; Bole S; Caulier A; Courbon C; Delorme J; Fournier I; François G; Jaivenois MF; Le Bars L; Mussot I; Vercasson M; Wallart Brejaud A; Yakoub-Agha I; Lacroix D
Bull Cancer; 2020 Dec; 107(12S):S170-S177. PubMed ID: 32891406
[TBL] [Abstract][Full Text] [Related]
16. [A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Broussais F; Vasseur A; Karam M; Chaillou D; Pereira M; Yakoub-Agha I; Raus N
Bull Cancer; 2021 Dec; 108(12S):S82-S86. PubMed ID: 33933288
[TBL] [Abstract][Full Text] [Related]
17. Building blocks for institutional preparation of CTL019 delivery.
McGuirk J; Waller EK; Qayed M; Abhyankar S; Ericson S; Holman P; Keir C; Myers GD
Cytotherapy; 2017 Sep; 19(9):1015-1024. PubMed ID: 28754600
[TBL] [Abstract][Full Text] [Related]
18. CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?
Pegram HJ; Smith EL; Rafiq S; Brentjens RJ
Immunotherapy; 2015; 7(5):545-61. PubMed ID: 26065479
[TBL] [Abstract][Full Text] [Related]
19. [Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].
Zephir H; Puyade M; Gueguen A; Michel L; Terriou L; Dive D; Laureys G; Mathey G; Labauge P; Marjanovic Z; Pugnet G; Badoglio M; Lansiaux P; Yakoub-Agha I; Béguin Y; Farge D
Bull Cancer; 2019 Jan; 106(1S):S92-S101. PubMed ID: 30527815
[TBL] [Abstract][Full Text] [Related]
20. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.
Gill S; June CH
Immunol Rev; 2015 Jan; 263(1):68-89. PubMed ID: 25510272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]